medigraphic.com
ISSN 2007-6800 (Print)

2023, Number 1

<< Back Next >>

Rev Mex Traspl 2023; 12 (1)

Cadaveric liver donor with SARS-CoV-2-positive

Martínez-Navarro M, Sánchez-Ojeda M, López-Falcony R, Soto-Granados O, Enrique-Sánchez J, Luna-López G

Language: Spanish
References: 13
Page: 41-44
PDF size: 256.12 Kb.


ABSTRACT

Coronavirus disease (COVID-19) has caused a negative impact on cadaveric organ donation processes in the world. Medical evidence has suggested evaluating the mortality risk of the recipient and the risk of transmission from the surgical team in the decision to use SARS-CoV-2-positive donors. In this case, we report the process of an asymptomatic SARS-CoV-2-positive cadaveric liver donor for a recipient patient with primary liver failure due to thrombosis of the hepatic artery classified as a transplant emergency. The present case may set a precedent for donation and transplant programs to begin considering asymptomatic SARS-CoV-2-positive donors with a high cycle threshold (Ct), for recipients with high mortality and/or morbidity who can potentially benefit.


REFERENCES

  1. Wall AE, McKenna GJ, Onaca N et al. Utilization of a SARS-CoV-2-positive donor for liver transplantation. Proc (Bayl Univ Med Cent). 2021; 35 (1): 62-63. doi: 10.1080/08998280.2021.1985888.

  2. Romagnoli R, Gruttadauria S, Tisone G et al. Liver transplantation from active COVID-19 donors: a lifesaving opportunity worth grasping? Am J Transplant. 2021; 21 (12): 3919-3925. doi: 10.1111/ajt.16823.

  3. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020; 5 (5): 428-430. doi: 10.1016/S2468-1253(20)30057-1.

  4. Eichenberger EM, Kaul DR, Wolfe CR. The pandemic provides a pathway: What we know and what we need to know about using COVID positive donors. Transpl Infect Dis. 2021; 23(5):e13727. doi: 10.1111/tid.13727.

  5. Aburto-Morales JS. La pandemia por SARS-CoV-2 (COVID-19) y el replanteamiento de las estrategias en la actividad de donación y trasplantes. Rev Mex Traspl. 2020; 9 (2): 49-50. doi: 10.35366/95706.

  6. Aburto-Morales JS, Romero-Méndez J, Lucio-García CA et al. México ante la pandemia de COVID-19 (SARS-CoV-2) y las recomendaciones al Subsistema Nacional de Donación y Trasplante. Rev Mex Traspl. 2020; 9 (1): 6-14. doi: 10.35366/94024.

  7. Riley DS, Barber MS, Kienle GS et al. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. 2017; 89: 218-235. doi: 10.1016/j.jclinepi.2017.04.026.

  8. Ley General de Salud. Art 328. 12 de Julio 2018. Estados Unidos Mexicanos.

  9. Sigler R, Shah M, Schnickel G, et al. Successful heart and kidney transplantation from a deceased donor with PCR positive COVID-19. Transpl Infect Dis. 2021; 23 (5): 1-3. doi: 10.1111/tid.13707.

  10. Reglamento de la Ley General de Salud en materia de trasplantes. Art. 43. 26 de Marzo 2014. Estados Unidos Mexicanos.

  11. Cubelos FN, Sánchez JMR, Nuevo Guisado MT et al. Valor umbral de ciclo en la COVID-19 en pacientes asintomáticos. SEMERGEN. 2021; 47 (5): 355-356. doi: 10.1016/j.semerg.2021.06.003.

  12. Serrano-Cumplido A, Ruiz Garcia A, Segura-Fragoso A et al. Aplicación del valor umbral del número de ciclos (Ct) de PCR en la COVID-19. SEMERGEN. 2021; 47 (5): 337-341. doi: 10.1016/j.semerg.2021.05.003.

  13. Boan P, Marinelli T, Opdam H. Solid organ transplantation from donors with COVID-19 infection. Transplantation. 2022; 106 (4): 693-695. doi: 10.1097/TP.0000000000004074.




2020     |     www.medigraphic.com